Thyroid Cancer Trial, Recruiting (NCT06736015)

Thyroid Cancer Trial, Recruiting NCT06736015 Sponsor: Regina Elena Cancer Institute Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06736015 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be an adult aged 18 or older
Both men and women are welcome to participate
You must have thyroid nodules that were classified as "TIR 3A" (a specific category of uncertain or mildly abnormal results) based on a needle biopsy test (called a fine needle aspiration)
You must be willing and able to sign a written consent form agreeing to take part
The sample collected from your biopsy must contain enough material to be used for further laboratory testing (confirm with trial site)

Who may not be able to join:

You may not be eligible if you have already been diagnosed with thyroid cancer or another type of thyroid malignancy through a biopsy result other than TIR 3A
You may not be eligible if your thyroid hormone levels (specifically a hormone called TSH) are abnormal in a way that requires you to start taking a medication called L-Thyroxine
You may not be eligible if you are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marialuisa Appetecchia, MD, Regina Elena National Cancer Institute - IRCCS IFO

Phone: 0039 0652666026

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06736015

Sponsor: Regina Elena Cancer Institute

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 0039 0652666026

More information: https://clinicaltrials.gov/study/NCT06736015

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be an adult aged 18 or older
Both men and women are welcome to participate
You must have thyroid nodules that were classified as "TIR 3A" (a specific category of uncertain or mildly abnormal results) based on a needle biopsy test (called a fine needle aspiration)
You must be willing and able to sign a written consent form agreeing to take part
The sample collected from your biopsy must contain enough material to be used for further laboratory testing (confirm with trial site)

Who may not be able to join:

You may not be eligible if you have already been diagnosed with thyroid cancer or another type of thyroid malignancy through a biopsy result other than TIR 3A
You may not be eligible if your thyroid hormone levels (specifically a hormone called TSH) are abnormal in a way that requires you to start taking a medication called L-Thyroxine
You may not be eligible if you are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Regina Elena Cancer Institute

Registry

ClinicalTrials.gov

Start date

23 October 2024

Est. completion

30 March 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Evaluation of differences in elastosonography after six months in patients treated with selenium and myo-inositol and patients not treated (controls)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov